Supportive Care in Cancer

, Volume 14, Issue 3, pp 260–267 | Cite as

Complementary and alternative medicine use in breast cancer patients in Europe

  • Alexander MolassiotisEmail author
  • Julia A. Scott
  • Nora Kearney
  • Dorit Pud
  • Miriam Magri
  • Sarka Selvekerova
  • Ingrid Bruyns
  • Paz Fernadez-Ortega
  • Vassiliki Panteli
  • Anita Margulies
  • Gudbjorg Gudmundsdottir
  • Ljiljana Milovics
  • Gulten Ozden
  • Nurgun Platin
  • Elisabeth Patiraki
Original Article


Complementary and alternative medicine (CAM) has gained popularity among cancer patients in the past years. For this study, CAM includes any group of health care systems, practices or products that are not considered to be part of conventional medicine at present (National Center for Complementary and Alternative Medicine). The present study assessed patterns of CAM use in breast cancer patients in Europe. The study used a descriptive cross-sectional design, and data were collected through a 27-item questionnaire. The sample, which was part of a larger study, consisted of 282 breast cancer patients from 11 countries in Europe. Among participants, 44.7% used CAM since their diagnosis of cancer. The most common therapies used included herbal medicine (46.4%) and medicinal teas, relaxation techniques, spiritual therapies, homeopathy and vitamins/minerals. Younger patients with higher education and who had received combination treatments for their cancer in the past were more likely to use CAM. High levels of satisfaction were reported, with only 6.5% of the women reporting no benefits from the CAM used. Main sources of information about CAM were mostly friends/family and the media. Findings suggested that a high proportion of breast cancer patients used CAM, which may have implications for the clinical management of these patients.


Complementary medicine Alternative medicine Complementary therapies Breast cancer Europe 


  1. 1.
    Ashikaga T, Bosompra K, O’Brien P, Nelson L (2002) Use of complimentary and alternative medicine in breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542–548Google Scholar
  2. 2.
    Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515–2521PubMedGoogle Scholar
  3. 3.
    Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739CrossRefPubMedGoogle Scholar
  4. 4.
    DiGianni LM, Garber JE, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20(18s):34s–38sPubMedGoogle Scholar
  5. 5.
    Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89PubMedGoogle Scholar
  6. 6.
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575CrossRefPubMedGoogle Scholar
  7. 7.
    Ernst E (2000) Possible interactions between synthetic and herbal medicinal products. Part I: a systematic review of the indirect evidence. Perfusion 13:4–6, 8Google Scholar
  8. 8.
    Ernst E (2000) Herbal medicines: where is the evidence? BMJ 321:395–396CrossRefPubMedGoogle Scholar
  9. 9.
    Fisher P, Ward A (1994) Complementary medicine in Europe. BMJ 309:107–111PubMedGoogle Scholar
  10. 10.
    Ganz P, Desmond K, Leedham B et al (2000) Quality of life in long-term, disease free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 92:42–47CrossRefPubMedGoogle Scholar
  11. 11.
    Gertz MA, Bauer BA (2001) Caring (really) for patients who use alternative therapies for cancer. J Clin Oncol 19:4346–4349PubMedGoogle Scholar
  12. 12.
    Gilbar O, Iron G, Goren A (2001) Adjustment to illness of cancer patients treated by complementary therapy along with conventional therapy. Patient Educ Couns 44:243–249CrossRefPubMedGoogle Scholar
  13. 13.
    Graham JG, Quinn ML, Fabricant DS, Farnsworth NR (2000) Plants used against cancer—an extension of the work of Jonathan Hartwell. J Ethnopharmacol 73:347–377CrossRefPubMedGoogle Scholar
  14. 14.
    Gray RE, Fitch M, Goel V, Franssen E, Labrecque M (2003) Utilization of complementary/alternative services by women with breast cancer. J Health Soc Policy 16:75–84CrossRefGoogle Scholar
  15. 15.
    Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 10:52–57Google Scholar
  16. 16.
    Jacobson JS, Verret WJ (2001) Complementary and alternative therapy for breast cancer. The evidence so far. Cancer Pract 9:307–310CrossRefPubMedGoogle Scholar
  17. 17.
    Kiefer D, Shah S, Gardiner P, Wechkin H (2001) Finding information on herbal therapy: a guide to useful sources for clinicians. Altern Ther Health Med 7:74–78PubMedGoogle Scholar
  18. 18.
    Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47CrossRefPubMedGoogle Scholar
  19. 19.
    Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE (2002) Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 29:1445–1452PubMedGoogle Scholar
  20. 20.
    Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM-A, Platin N, Kearney N, Patiraki E (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663CrossRefPubMedGoogle Scholar
  21. 21.
    Morris KT, Johnson N, Homer L, Walts D (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179:407–411CrossRefPubMedGoogle Scholar
  22. 22.
    Moschen R, Kemmler G, Schweigkofler H, Holzner B, Dunser M, Richter R, Fleischhacker WW, Sperner-Unterweger B (2001) Use of alternative/complementary therapy in breast cancer patients—a psychological perspective. Support Care Cancer 9:267–274CrossRefPubMedGoogle Scholar
  23. 23.
    Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C (2000) Prevalence of complementary therapy use by women with breast cancer: a population based survey. Eur J Cancer 36:1359–1364CrossRefPubMedGoogle Scholar
  24. 24.
    Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMedGoogle Scholar
  25. 25.
    Ritvo P, Irvine J, Katz J, Matthew A, Sacamano MA, Shaw BF (1999) The patient’s motivation in seeking complementary therapies. Patient Educ Couns 38:161–165CrossRefPubMedGoogle Scholar
  26. 26.
    Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, Shekelle P (2002) Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2:8CrossRefPubMedGoogle Scholar
  27. 27.
    Shumay DM, Maskarinec G, Gotay CC, Heiby EM, Kakai H (2002) Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Altern Complement Med 8:661–671CrossRefPubMedGoogle Scholar
  28. 28.
    Smith M, Boon HS (1999) Counseling cancer patients about herbal medicine. Patient Educ Couns 38:109–120CrossRefPubMedGoogle Scholar
  29. 29.
    Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG (2002) Use of complementary and alternative medicine among women with gynaecologic cancers. Gynecol Oncol 84:363–367CrossRefPubMedGoogle Scholar
  30. 30.
    VandeCreek L, Rogers E, Lester J (1998) Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 5:71–76Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Alexander Molassiotis
    • 1
    Email author
  • Julia A. Scott
    • 2
  • Nora Kearney
    • 2
  • Dorit Pud
    • 3
  • Miriam Magri
    • 4
  • Sarka Selvekerova
    • 5
  • Ingrid Bruyns
    • 6
  • Paz Fernadez-Ortega
    • 7
  • Vassiliki Panteli
    • 8
  • Anita Margulies
    • 9
  • Gudbjorg Gudmundsdottir
    • 10
  • Ljiljana Milovics
    • 11
  • Gulten Ozden
    • 12
  • Nurgun Platin
    • 13
  • Elisabeth Patiraki
    • 8
  1. 1.School of NursingUniversity of ManchesterManchesterUK
  2. 2.Department of Nursing and MidwiferyUniversity of StirlingStirlingUK
  3. 3.Faculty of Social Welfare and Health StudiesUniversity of HaifaHaifaIsrael
  4. 4.Istituto Nazionale TumoriUniversità degli Studi di MilanoMilanItaly
  5. 5.Masaryk Memorial Cancer InstituteBrnoCzech Republic
  6. 6.Belgian Society of Oncology NursingBrusselsBelgium
  7. 7.Institut Català Oncologia ICOBarcelonaSpain
  8. 8.Greek Oncology Nursing SocietyAthensGreece
  9. 9.Klinik und Poliklinik für OnkologieUniversity Hospital ZürichZurichSwitzerland
  10. 10.Department of OncologyLandspitaliReykjavikIceland
  11. 11.Department of EducationInstitute for Oncology and RadiologyBelgradeSerbia and Montenegro
  12. 12.Gazi University HospitalAnkaraTurkey
  13. 13.School of Health SciencesKoc UniversityIstanbulTurkey

Personalised recommendations